Business

AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Management will participate in a fireside chat at 9:00 a.m. Central time.

articleAbbvie Inc.September 2, 20251/company/abbvie-inc/news/abbvie-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference
AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

About this update from Abbvie Inc.

[{"type":"text","content":"NORTH CHICAGO, Ill., Sept. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025. Management will participate in a fireside chat at 9:00 a.m. Central time.","length":260,"tagName":"p"},{"type":"text","content":"A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.","length":201,"tagName":"p"},{"type":"text","content":"About AbbVie","length":12,"tagName":"p"},{"type":"text","content":"AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.","length":542,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Media:","length":6,"tagName":"p","attribs":{}},{"type":"text","content":"Gabby Tarbert   (224) 244-0111","length":41,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"Investors:","length":10,"tagName":"p","attribs":{}},{"type":"text","content":"Liz Shea (847) 935-2211","length":24,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"[email protected]","length":28,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"PADDING-RIGHT:0.17em;PADDING-LEFT:0.17em;VERTICAL-ALIGN:BOTTOM;","val":[{"type":"text","content":"[email protected]","length":19,"tagName":"p","attribs":{}}]}]}],"length":133},{"type":"image","alt":"AbbVie logo","displaySize":"","headline":null,"caption":"AbbVie logo","classN...

More updates from Abbvie Inc.

Morgan StanleyGlobal Healthcare ConferenceAbbViefireside chatInvestor Relations websitePRNewswire